Genpro Research Private Limited
Genpro Research is a next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry. Our tools use Artificial Intelligence, Machine Learning, and Natural Language Processing algorithms to enable automation of several processes throughout drug development and post-launch activities. We provide advanced solutions in Biostatistics & Programming, Medical Writing, and Regulatory Submissions.
Genpro has a diverse talent pool of professionals with several years of industry experience along with a young and energetic set of professionals from some of the leading institutions. Genpro has launched MaIA, an advanced end-to-end framework that increases efficiency and mitigates the pain points of literature reviews. This platform quickly produces quality literature review summaries/ disease context summaries/ TA landscaping and Systematic Literature Reviews (SLRs) for Epidemiology, medical affairs, and medical information teams. It can reduce the cognitive workload of the writers and analysis by 50-70%. MaIA was co-developed and tested with one of the world's top five pharma company.
Genpro brings together the global best practices in Clinical Data Management, Biostatistics, Programming, Medical Writing, and Strategic Consulting. We deliver cost-effective solutions to our clients on time with international quality.
Since Genpro's inception, we have had a fast and ambitious scale-up plan and have established offices in Waltham, USA, and India development centres in Thiruvananthapuram, and Baroda. Each of these offices have a specialty function which helps us cater our customers effectively.
Genpro provides excellent work-life balance by adopting global Flexi work practices. Genpro team has been working for more than 15 years in NDA/ BLA/PMA submissions, interacting with FDA/ EMEA & PMDA, and actively collaborating with academic, industry, and FDA working groups.
